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Abstract Several site directed mutations were introduced into a
synthetic Noxiustoxin (NTX) gene. Alanine scanning of the
nonapeptide at the N-terminal segment of NTX (threonine 1 (T1)
to serine 9 (S9)) was constructed and the recombinant products
were obtained in pure form. Additionally, lysine 28 (K28) was
changed to arginine (R) or glutamic acid (E), cysteine 29 was
changed to alanine, and residues 37^39 (Tyr-Asn-Asn) of the
carboxyl end were deleted. The recombinant mutants were tested
for their ability to displace 125I-NTX from rat brain synapto-
some membranes, as well as for their efficiency in blocking the
activity of Kv1.1 K+ channels expressed in Xenopus laevis
oocytes. The main results indicate that residues K6, T8 at the
amino end, and K28 and the tripeptide YNN at the carboxyl end
are involved in specific interactions of NTX with rat brain and/or
Kv1.1 K+ channels.
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1. Introduction
Scorpion toxins are very useful tools for the study of ion
channels [1]. NTX, a 39 amino acid peptide puri¢ed from the
Mexican scorpion Centruroides noxius Ho¡mann [2], was the
¢rst reported animal toxin described as a speci¢c K channel
blocker [3]. NTX can reversibly block several types of K
channels [3^5]. K channels are tetrameric membrane proteins
involved in many biological phenomena [6^8], with a large
variety of gating mechanisms and kinetics, but with a high
selectivity for K ions [6]. Each monomer is composed of
six transmembrane segments connected by loops. The loops
located between segments S5 and S6, of each monomer, were
proposed to form the pore of the channel and are responsible
for its ion selectivity [9,10]. Apart from the pore itself, it has
been proposed that loops S5-S6 conform a vestibule which
has been demonstrated to be the target site for many toxins
that have in common the capacity of occluding the pore of the
channel [11]. The speci¢c interaction of toxins from di¡erent
sources with de¢ned residues of the vestibule and the pore is
under intensive study [7^12]. Scorpion toxins that a¡ect K
channels are short peptides (31^40 amino acid residues), with
a well conserved three-dimensional structure stabilized by 3^4
disul¢de bridges [13]. In spite of this conserved structure and
small size, di¡erences in sequence are involved in their specif-
icity toward di¡erent K channels. Scorpion toxins whose
three-dimensional structures are known, have been key tools
for revealing the putative architecture of the ion-channel pore
in the absence of direct evidence [10^12]. Cyclic mutagenesis
of channel and toxin amino acid residues has revealed those
residues that are critical for the speci¢c interaction channel-
toxin [9^11]. In this communication we report an analysis of
the interaction of a recombinant NTX and a series of mu-
tants, with K channels present in rat brain synaptosome
membranes and/or Kv1.1 K channels expressed in Xenopus
laevis oocytes, in order to identify the interacting epitope of
NTX towards these channels.
2. Materials and methods
2.1. Synthesis of oligonucleotides and generation of NTX mutants
Mutant oligonucleotides were synthesized on a PerSeptive Biosys-
tems Expedite Model 8905 nucleic acid synthesis system using stand-
ard cyanoethyl phosphoramidite chemistry. A previously designed
synthetic NTX gene [14], was used as template to generate the mu-
tants here analyzed. Mutants were obtained by means of PCR using a
series of mutagenic oligonucleotides as described [14]. Residues 1^9
from the amino terminus were changed to alanine (alanine scanning),
using oligonucleotides that contained nine nucleotides at the 3P side of
the corresponding mutant codon (GCT, alanine) and a variable size at
the 5P side. All these mutagenic oligonucleotides of the amino termi-
nus of NTX started at the sequence CGGATTCT, which is located
¢ve nucleotides downstream from the 5P end of oligonucleotide No. 1
used previously for the synthesis of NTX gene [14]. The second primer
for these PCR reactions was oligonucleotide No. 6 from the same
work [14]. Amino terminus mutants were rescued in a second PCR
with oligonucleotides Nos. 1 and 6 [14]. Deletion mutant (vYNN,
residues 37^39), was generated with oligonucleotide No. 4 [14], from
which the ¢rst three nucleotides of 5P end were deleted. The second
primer for this PCR was oligonucleotide No. 1 [14]. Rescuing of this
mutant was done with oligonucleotide 1 and modi¢ed oligonucleotide
6 from which the last two nucleotides of the 3P end were deleted and
substituted by nine nucleotides complementary to codons for residues
34^36. In the case of mutants of residue K28 (K28R and K28E) and
C29A, the recursive PCR technique [15] was used as previously de-
scribed [14], in which mutant codons were carried by oligonucleotide
No. 3 [14]. The substitution of the cysteines at positions 7 and 29 was
done as a double mutation, in order to eliminate one of the disul¢de
bridges and avoid having free thiol groups that could make polymeric
NTX. All mutations were veri¢ed by nucleotide sequencing as de-
scribed [14]. Amino acid sequence of the mutants was determined
by automated Edman degradation. Recombinant NTX and derived
mutants were expressed and puri¢ed as described [14]. The vector
pCSP105 used for expression of recombinant and mutant NTXs
was generously given to us by Dr. Christopher Miller, Brandeis Uni-
versity, Walthman Massachusetts, USA.
2.2. Binding and displacement assays
Rat brain synaptosome membranes were prepared as described [14].
Fraction P3 of this preparation was used for binding assays. 125I-NTX
was labeled with the peroxidase method as described [16]. Native and
recombinant NTXs and all the NTX mutants generated in this study
were tested, except the double mutant C7A-C29A, which was not
obtained in properly folded and puri¢ed form.
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2.3. Electrophysiological recording
pGEMHE vector (kindly provided by Dr. Mauricio Montal, Uni-
versity of California, San Diego, CA, USA), containing the cDNA
that encodes mouse brain Kv1.1 channel was transcribed in vitro, as
described [17]. Oocytes obtained from adult Xenopus laevis (Nasco,
Fort Atkinson, USA), were injected with Kv1.1 RNA as reported by
Ferrer-Montiel and Montal [17], and maintained at 17‡C for 48 h in
the recording solution (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2,
5 HEPES, 2.5 sodium pyruvate pH 7.6), containing 50 Wg/ml genta-
micin. Channels were expressed to a level of 5^10 WA outward cur-
rent, elicited by 50 ms depolarizations from a holding potential of
370 mV to potentials between 330 mV and +30 mV in steps of
15 mV. The time between pulses was 15 s and all currents were
recorded at 18^20‡C. Oocyte membrane potential was controlled
and current recorded by means of a two electrode voltage clamp
ampli¢er (model CA1a, DAGAN Co., USA). Electrodes were ¢lled
with a solution containing: 1 M KCl, 10 mM EGTA and 10 mM
HEPES pH 7.4, which had resistances from 0.3 to 1 m6. Currents
were ¢ltered at 2 kHz and sampled every 100 Ws (10 kHz), using the
Digidata 1200 interface (Axon Instruments, Burlingame, USA). Lin-
ear capacitive and leakage currents were removed on line with a P/-4
pulse protocol. Currents were recorded in the absence and presence of
toxins. The recording reservoir was washed with 30 ml recording
solution during 3 min, thereafter, currents were recorded periodically
to verify recovery from toxin blockade. Native, recombinant and mu-
tant K6A, T8A, K28R, K28E and vYNN37^39 NTXs were tested in
this assay.
3. Results and discussion
3.1. Design of mutated recombinants of NTX
The rationale guiding the design of the mutants prepared
and used in the present work was based on previous results :
(a) our laboratory showed that the N-terminal nonapeptide of
NTX was toxic per se to mice [18,19] or was able to recognize
Ca2-dependent K channels from aortic tissue [20]; (b) sev-
eral laboratories have shown that similar toxins, i.e. Charyb-
dotoxin (ChTX) [11] and Agitoxin 2 (AgTX) [12] have a cru-
cial lysine residue (K27 for Charybdotoxin), in equivalent
positions as that of K28 for NTX, shown to be very impor-
tant for channel blockade, and (c) the fact that amidation of
asparagine at the C-terminal region of NTX makes no di¡er-
ence on binding of radiolabeled NTX to brain synaptosome
membranes [14], as well as that a synthetic decapeptide from
the C-terminal segment of NTX had no e¡ect on binding
displacement experiments [19]. All the peptides were obtained
in pure form and in enough quantities to conduct the experi-
ments described below, except as mentioned before, the dou-
ble mutant (C7A-C29A), which eliminated one of the three
disul¢des of NTX.
3.2. Binding and displacement of native, recombinant and
mutant NTXs
Recombinant NTX (NTXr) displaced labeled native NTX
(125I-NTX) from synaptosome membranes in a very similar
manner as cold native NTX (NTXn) did (Fig. 1, panel A).
The same results were obtained for mutants T1A, I2A, I3A,
N4A, V5A, K6A, T8A and S9A. Only data for mutants T1A
and I2A are shown in panel B of Fig. 1. Variants vYNN (Fig.
1, panel C) and K28E (Fig. 1, panel D) displayed shifts to
lower displacements of approximately three orders of magni-
tude, whereas the mutant K28R had no signi¢cant e¡ect.
Also, in contrast to our previous work with synthetic peptides
on the binding assay to brain synaptosome membranes [19]
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Fig. 1. Binding inhibition of 125I native NTX by non-labeled native,
recombinant and mutant NTXs to synaptosomal membranes. Rat
brain synaptosomes were incubated with 125I-NTX at 100 pM in the
absence of native, recombinant or mutant NTXs (100% binding).
Binding inhibition of 125I-NTX to synaptosomes by increasing con-
centrations of cold native, recombinant or mutant NTXs is repre-
sented by the curves shown. Values are the mean of experiments
carried out in triplicate. Double symbols in panel A refer to two in-
dependent experiments by triplicate.
Fig. 2. Blocking assays on Kv1.1 channels of native, recombinant
and mutant NTXs. Kv1.1 channels were expressed in X. laevis oo-
cytes (for details see Section 2.3). Left part of this ¢gure shows the
fraction of current blocked with di¡erent concentrations of native,
recombinant or mutant NTXs. Values are the means of 3^7 meas-
urements. Standard deviations are also shown (only upper or lower
values are drawn for clarity). Inset: K blockade currents by native
(a) or recombinant (b) NTXs at a concentration of 10 nM. Contin-
uous lines represent control currents, broken lines show currents in
the presence of the toxin, dotted lines indicate the current recovered
after toxin washing. These recordings correspond to a potential of
0 mV from a holding potential of 370 mV.
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and to Ca2-dependent K channels from bovine aorta [20],
no signi¢cant di¡erences were found between binding dis-
placement assays of native NTX and those of the N-terminal
segment of the mutated NTXs. Alanine scanning has been
considered a reliable approach to evaluate the importance of
de¢ned amino acid side chains on the function of a protein
[21,22]. Thus, based on the results presented in Fig. 1, it can
be concluded that K28 and the tripeptide Y37-N39 are im-
portant residues involved in the binding capacity of NTX to
populations of K channels present in rat brain synaptosome
membranes.
3.3. Electrophysiological assays
Recombinant NTX blocked Kv1.1 channel in a comparable
manner as native NTX (Fig. 2). Washing of the corresponding
toxin bound to the channels allowed a recovery of more than
90% of the control current (Fig. 2, inset), indicating that toxin
binding is reversible. Mutants K6A, T8A, K28R, K28E and
vYNN showed a lower blocking capacity compared to native
or recombinant NTX (Fig. 2). Some mutants behaved di¡er-
ently in the electrophysiological assay with Kv1.1 channel,
and in the synaptosome system. Mutants K6 and T8 were
less potent blockers of Kv1.1 than the native or recombinant
NTXs, whereas in the synaptosome binding assay they
showed no di¡erence. The T8 mutant displayed a higher
blocking activity than K6 (Fig. 2). This result suggests that
position K6 represents one of the critical interactions of NTX
with Kv1.1 channel, which is consistent with our previous
work [19,20].
The mutant K28R, on the oocyte expressed K channels,
displayed a lower blocking capacity, whereas in the synapto-
some system there was no di¡erence with regard to native
NTX, indicating that the side chain of K28 is critical for
blocking channels of the Kv1.1 type. However, the apparent
contradiction of the results obtained with the K28R mutant
and the N-terminal mutants of NTX1-9 on synaptosome
membranes, is solely con¢rmatory that for valid comparisons
we need to have de¢ned channels with de¢ned toxins. Much
work still remains to be done, using both natural and re-
combinant mutant toxins with respect to di¡erent channels,
to obtain information about the structure of the channels
using toxin-channel interactions. Mutants K28E and vYNN
showed equivalent e¡ects in both systems, indicating that K28
and the carboxyl end of NTX are important for binding to
both rat brain K channels and mouse Kv1.1 channels. Sim-
ilar results were obtained for this critical lysine residue in
ChTX and AgTX [11,12]. In conclusion, residues K6, T8,
K28 and tripeptide YNN37^39 are important for binding to
Kv1.1 channel. Equivalent K28 residues in other scorpion
toxins have been shown to be one of the most critical residues
for the interaction of these toxins with their respective chan-
nels [11,23]. The carboxyl end (YNN) deletion mutant also
showed an important reduction in its blocking capacity to-
wards Kv1.1 channel, whereas the amidated or non-amidated
forms of N39 are irrelevant for the e¡ect in both brain and
oocyte assays. A synthetic homolog toxin (Margatoxin,
MgTX, 79% homology), in which the last three residues of
the carboxyl terminus were deleted, exhibited a 7500-fold de-
crease in its relative a⁄nity to Jurkat cell membranes, which
are enriched in Kv1.3 channels [24]. It has been shown that
the carboxyl terminus is important in Charybdotoxin for
channel binding [25]. These results indicate that K28 and
the carboxyl end (YNN) in NTX are important both for bind-
ing to synaptosome membranes and for blocking Kv1.1 chan-
nel. When the three-dimensional models of ChTX and AgTX
are compared to NTX (data not shown), it can be observed
that residues at equivalent positions to Y37 and N39 of NTX,
are present in ChTX and AgTX. These residues have been
shown to be critical for channel blocking [11,12]. If the
three-dimensional models of scorpion toxins that block K
channels are compared to anemone K channel toxins whose
three-dimensional structure are known (data not shown), it
also can be observed that functionally equivalent residues to
K28 and carboxyl end residues of NTX (in particular Y37),
are found in the anemone toxins at approximately the same
spacial location, despite the fact that the three-dimensional
foldings of scorpion and anemone toxins are quite di¡erent
[26]. These observations indicate a functional convergence be-
tween scorpion toxins and anemone toxins that block K
channels and probably a recurrent theme in other animal
K channel blockers.
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